trending Market Intelligence /marketintelligence/en/news-insights/trending/10z6mwm3rkwhvoupficr8g2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

IntelGenx drops plans to buy pharmaceutical consulting firm

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


IntelGenx drops plans to buy pharmaceutical consulting firm

IntelGenx Technologies Corp. said March 27 that it is no longer looking to raise $10 million to fund the acquisition of a pharmaceutical consulting firm.

The company canceled its placement due to market conditions. The Canadian drug delivery company's acquisition of LaboVal Inc. was dependent on the financing.